# Clinical trials recruiting in Wisconsin: 1,301 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,301 trials recruiting or not yet recruiting with a site in Wisconsin, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Wisconsin: 1,301 rows for $65.05, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 13 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/wisconsin

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,301
- Recruiting or not yet: 1,301
- Read on: November 19, 2026

## Trials

The 25 newest of 1,301, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07943377 | Safety, Tolerability, and Pharmacokinetics of Supratherapeutic Doses of ALG-000184 (Parts A and B) and the Absorption, Metabolism... | Aligos Therapeutics | Phase 1 | Not yet recruiting | Healthy Participants | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943377) |
| November 16, 2026 | NCT07938203 | MitoQ Supplementation for Microvascular Health and Stroke Recovery | Medical College of Wisconsin | Phase 2 | Not yet recruiting | Stroke, Stroke Recurrence | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938203) |
| November 13, 2026 | NCT07935889 | Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 Trial | Mayo Clinic | Phase 3 | Recruiting | Glioblastoma, IDH-Wildtype | 292 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935889) |
| November 12, 2026 | NCT07933523 | LDRT Retreatment for Knee Osteoarthritis | University of Wisconsin, Madison | Phase 2 | Not yet recruiting | Osteoarthitis, Osteoarthritic Knee Pain | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933523) |
| November 12, 2026 | NCT07932782 | Patient-Centered Clinical Trial Navigation: Addressing Gender Disparity in Clinical Trial Participation | Medical College of Wisconsin | Not applicable | Not yet recruiting | Breast Cancer | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932782) |
| November 9, 2026 | NCT07924800 | Improving Labor Management for Patients With Severe Obesity Using Abdominal Pannus Retraction | Medical College of Wisconsin | Not applicable | Not yet recruiting | Birth Length, Severe Obesity | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924800) |
| November 9, 2026 | NCT07924605 | PSMA PET/MRI for Predicting and Detecting Prostate Cancer | University of Wisconsin, Madison | Phase 2 | Not yet recruiting | Prostate Cancer, High-Risk Localized Prostate Cancer, Locally Advanced Prostate Cancer, Low-Risk Prostate Cancer... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924605) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 2, 2026 | NCT07910474 | FES PET/MRI for Occult Disease in Lobular Breast Cancer | University of Wisconsin, Madison | Phase 4 | Recruiting | Lobular Breast Carcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910474) |
| November 2, 2026 | NCT07909733 | Maintenance Treatment With Imetelstat in Patients With High-Risk Myeloid Neoplasms After Allo-SCT | University of Wisconsin, Madison | Phase 1 | Not yet recruiting | High-risk Myeloid Malignancy, Allogenic Stem Cell Transplantation, Acute Myeloid Leukemia (AML), Chronic Myeloid... | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909733) |
| November 2, 2026 | NCT07909720 | The EYERISING Study | University of Wisconsin, Madison | Not applicable | Not yet recruiting | Myopia, Astigmatism, Anisometropia | 333 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909720) |
| November 2, 2026 | NCT07908316 | Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After... | Amgen | Phase 1 | Recruiting | Obesity, Overweight | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908316) |
| October 30, 2026 | NCT07908056 | Evaluate Precision of the Test for Lactate in Capillary Whole Blood Specimens Using the i-STAT CG4+ Cartridge With the i-STAT 1 Analyzer | Abbott Point of Care | Observational | Not yet recruiting | Lactate | 425 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908056) |
| October 27, 2026 | NCT07896811 | Triplet Immunotherapy For Exhausted Cell Targets in Advanced Squamous Cell Carcinoma | Medical College of Wisconsin | Phase 2 | Not yet recruiting | Squamous Cell Carcinoma | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896811) |
| October 27, 2026 | NCT07896408 | Foodservice Robots Engaging Senior Health | University of Wisconsin, Madison | Not applicable | Not yet recruiting | Elder | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07896408) |
| October 22, 2026 | NCT07890610 | Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest | Children's Hospital of Philadelphia | Observational | Recruiting | Cardiac Arrest (CA) | 1,620 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890610) |
| October 19, 2026 | NCT07881692 | GOT VOICE Feasibility With In-Person Group Singing | Medical College of Wisconsin | Not applicable | Not yet recruiting | Elderly, Coronary Arterial Disease (CAD) | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881692) |
| October 13, 2026 | NCT07870746 | Phase 2a Study to Assess Safety and Efficacy of Two 177Lu-TLX250 Dosing Regimens in Advanced Relapsed or Recurrent ccRCC | Telix Pharmaceuticals (Innovations) Pty Limited | Phase 2 | Not yet recruiting | ccRCC, Renal Cell Carcinoma (Kidney Cancer), Renal Cell Carcinoma (RCC), Renal Cell Cancer Metastatic, Renal Cell... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07870746) |
| October 9, 2026 | NCT07867327 | A Study of LY4515100 in Healthy Male Participants | Eli Lilly and Company | Phase 1 | Recruiting | Healthy | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867327) |
| October 9, 2026 | NCT07867080 | A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME). | 4D Molecular Therapeutics | Phase 3 | Recruiting | Diabetic Macular Edema (DME) | 514 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867080) |
| October 6, 2026 | NCT07861100 | A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Cardiovascular Risk, Obesity | 8,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861100) |
| October 5, 2026 | NCT07856927 | To Share or Not To Share: Navigating Disclosure and Stigma Among Family Caregivers of Autistic Young Adults\_Group Intervention | University of Wisconsin, Madison | Not applicable | Recruiting | Autism | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856927) |
| September 29, 2026 | NCT07845487 | A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis | Sponsor not shown (see the record) | Phase 2 | Recruiting | Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis | 204 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845487) |
| September 23, 2026 | NCT07836959 | Hybrid III Trial of Automated Referral to Comprehensive Geriatric Assessment for Frail Older Surgical Patients | University of Wisconsin, Madison | Not applicable | Not yet recruiting | Elective Surgery, Frail Elderly | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07836959) |
| September 18, 2026 | NCT07828613 | Accelerated Flap Coverage Versus Standard Timing in the Treatment of Severe Lower Extremity Musculoskeletal Injuries | Johns Hopkins University | Not applicable | Not yet recruiting | Open Tibia Fracture, Open Dislocation of Ankle, Extremity Fracture Lower, Extremity Injuries Lower | 356 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828613) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Medical College of Wisconsin | Milwaukee | 249 |
| University of Wisconsin | Madison | 111 |
| Marshfield Medical Center-Marshfield | Marshfield | 89 |
| University of Wisconsin Carbone Cancer Center - University Hospital | Madison | 89 |
| Marshfield Medical Center - Weston | Weston | 77 |
| Saint Vincent Hospital Cancer Center Green Bay | Green Bay | 77 |
| Marshfield Medical Center-River Region at Stevens Point | Stevens Point | 72 |
| Gundersen Lutheran Medical Center | La Crosse | 70 |
| Duluth Clinic Ashland | Ashland | 67 |
| Marshfield Medical Center-EC Cancer Center | Eau Claire | 65 |
| Marshfield Medical Center-Rice Lake | Rice Lake | 64 |
| University of Wisconsin Carbone Cancer Center - Eastpark Medical Center | Madison | 60 |
| Saint Vincent Hospital Cancer Center at Saint Mary's | Green Bay | 58 |
| Saint Vincent Hospital Cancer Center at Sturgeon Bay | Sturgeon Bay | 56 |
| Cancer Center of Western Wisconsin | New Richmond | 55 |
| Aurora BayCare Medical Center | Green Bay | 53 |
| Aurora Sinai Medical Center | Milwaukee | 52 |
| Aurora West Allis Medical Center | West Allis | 51 |
| Marshfield Medical Center - Minocqua | Minocqua | 51 |
| ProHealth D N Greenwald Center | Mukwonago | 50 |
| ProHealth Oconomowoc Memorial Hospital | Oconomowoc | 50 |
| UW Cancer Center at ProHealth Care | Waukesha | 50 |
| Aurora Cancer Care-Grafton | Grafton | 50 |
| Aurora Saint Luke's Medical Center | Milwaukee | 50 |
| Vince Lombardi Cancer Clinic - Oshkosh | Oshkosh | 50 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 9 |
| Phase 1 | 106 |
| Phase 1/2 | 63 |
| Phase 2 | 239 |
| Phase 2/3 | 39 |
| Phase 3 | 319 |
| Phase 4 | 42 |
| Not applicable | 270 |
| Observational | 214 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Breast Neoplasms | 50 |
| Carcinoma, Non-Small-Cell Lung | 50 |
| Neoplasms | 49 |
| Prostatic Neoplasms | 48 |
| Neoplasm Metastasis | 37 |
| Colorectal Neoplasms | 36 |
| Lung Neoplasms | 36 |
| Multiple Myeloma | 35 |
| Leukemia, Myeloid, Acute | 30 |
| Ovarian Neoplasms | 29 |
| Pancreatic Neoplasms | 29 |
| Endometrial Neoplasms | 24 |
| Lymphoma, Follicular | 23 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 22 |
| Heart Failure | 22 |
| Lymphoma, Non-Hodgkin | 22 |
| Melanoma | 22 |
| Lymphoma, Large B-Cell, Diffuse | 21 |
| Recurrence | 21 |
| Stomach Neoplasms | 19 |
| Urinary Bladder Neoplasms | 18 |
| Squamous Cell Carcinoma of Head and Neck | 16 |
| Carcinoma | 16 |
| Hematologic Neoplasms | 16 |
| Burkitt Lymphoma | 16 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University of Wisconsin, Madison | 164 |
| Medical College of Wisconsin | 115 |
| National Cancer Institute (NCI) | 63 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 37 |
| SWOG Cancer Research Network | 26 |
| Children's Oncology Group | 25 |
| Alliance for Clinical Trials in Oncology | 22 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 20 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 20 |
| NRG Oncology | 19 |
| Mayo Clinic | 19 |
| VA Office of Research and Development | 19 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 14 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 13 |
| Wake Forest University Health Sciences | 11 |
| ECOG-ACRIN Cancer Research Group | 11 |
| Marquette University | 10 |
| Duke University | 10 |
| [BeOne Medicines](https://specstream.ai/data/clinical-trials/company/beone-medicines) | 10 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 9 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 8 |
| [Daiichi Sankyo](https://specstream.ai/data/clinical-trials/company/daiichi-sankyo) | 8 |
| [Incyte Corporation](https://specstream.ai/data/clinical-trials/company/incyte-corporation) | 8 |
| New York Medical College | 8 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 8 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Wisconsin

- [Security companies in Wisconsin, United States](https://specstream.ai/data/businesses/security-companies/wisconsin-united-states)
- [Beverage suppliers in Wisconsin, United States](https://specstream.ai/data/businesses/beverage-suppliers/wisconsin-united-states)
- [Food and beverage distributors in Wisconsin, United States](https://specstream.ai/data/businesses/food-and-beverage-distributors/wisconsin-united-states)
- [Oncology practices in Wisconsin, United States](https://specstream.ai/data/businesses/oncology-practices/wisconsin-united-states)
- [Truck repair shops in Wisconsin, United States](https://specstream.ai/data/businesses/truck-repair-shops/wisconsin-united-states)
- [Commercial refrigeration companies in Wisconsin, United States](https://specstream.ai/data/businesses/commercial-refrigeration-companies/wisconsin-united-states)
